Search Results 231-240 of 11392 for anti-TNF drugs

1. Fosphenytoin (injection route) - Side effects & uses - Mayo Clinic

   ... drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the ...

2. A Multi-center Study A Single IV Infusion Of Allogeneic MPCs In Patients With Rheumatoid Arthritis And Incomplete Response To At Least One TNF Alpha Inhibitor - Mayo Clinic

   Use of TNFα inhibitor for treatment of RA at time of screening or within the 6 weeks prior to screening. Prior use of biologics for treatment of RA ...

3. Atypical antidepressants - Mayo Clinic

   Vilazodone (Viibryd); Vortioxetine (Trintellix). A new antidepressant called esketamine (Spravato) is FDA approved for treatment-resistant depression.

4. Clinical trials - Oncology (Medical)

   ... the study drug is on its own and in combination with other anti-cancer drugs (bevacizumab, cemiplimab, fianlimab, REGN10597 and a standard chemotherapy drug ...

5. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy And Safety Study Of SHP647 As Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo ... Subjects have received anti-TNF treatment within 60 days before baseline (Visit 2).

6. Sunitinib (oral route) - Mayo Clinic

   Sunitinib is used to treat a gastrointestinal stromal tumor (GIST) after other medicines (eg, imatinib) did not work very well. It may also be used when ...

7. Examining the efficacy of recombinant zoster vaccination in patients with IBD - Mayo Clinic

   "For example, prednisone, thiopurines, anti-TNFs and JAK inhibitors are associated with a significantly increased risk of shingles in patients with IBD." Dr ...

8. Trial Using Keytruda As Initial Therapy In The Treatment Of Advanced Mycosis Fungoides - Mayo Clinic

   About this study. The purpose of this trial is to evaluate the antitumor activity of Pembrolizumab in patients with advanced mycosis fungoides (MF) as ...

9. Data From Worldwide Trial of Two HER2-Positive Breast Cancer Drugs Shows That Trastuzumab Should Remain as Standard of Care - Mayo Clinic News Network

   Dual blockade using two anti-HER2 drugs only increased toxicity, said Dr. Perez. This new analysis compared use of lapatinib or trastuzumab alone, as well ...

10. Safety and Immune Response of the COVID 19 Vaccine in Patients with Inflammatory Bowel Disease - Mayo Clinic

    ustekinumab mono or combination therapy;; patients on mesalamine or no therapy. Group B (Low vaccine responders):. Anti-TNF monotherapy;; anti-TNF combination ...